Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Balance Sheet
Balance Sheet Decomposition
Nichi-Iko Pharmaceutical Co Ltd
Current Assets | 177.1B |
Cash & Short-Term Investments | 13.3B |
Receivables | 70.3B |
Other Current Assets | 93.4B |
Non-Current Assets | 69.4B |
Long-Term Investments | 11.1B |
PP&E | 35.9B |
Intangibles | 22.2B |
Other Non-Current Assets | 238m |
Current Liabilities | 182.6B |
Accounts Payable | 40.7B |
Other Current Liabilities | 141.9B |
Non-Current Liabilities | 99.7B |
Long-Term Debt | 71.8B |
Other Non-Current Liabilities | 27.9B |
Balance Sheet
Nichi-Iko Pharmaceutical Co Ltd
Mar-2013 | Mar-2014 | Mar-2015 | Mar-2016 | Mar-2017 | Mar-2018 | Mar-2019 | Mar-2020 | Mar-2021 | Mar-2022 | ||
---|---|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||||
Cash & Cash Equivalents |
5 309
|
21 695
|
14 032
|
28 179
|
12 457
|
18 529
|
42 093
|
42 944
|
29 142
|
15 305
|
|
Cash Equivalents |
5 309
|
21 695
|
14 032
|
28 179
|
12 457
|
18 529
|
42 093
|
42 944
|
29 142
|
15 305
|
|
Short-Term Investments |
0
|
1
|
0
|
0
|
366
|
974
|
447
|
425
|
3 715
|
425
|
|
Total Receivables |
26 312
|
27 794
|
21 162
|
24 405
|
31 703
|
28 986
|
28 526
|
38 521
|
36 514
|
34 521
|
|
Accounts Receivables |
26 312
|
27 794
|
21 162
|
24 405
|
29 311
|
27 219
|
26 573
|
36 045
|
33 762
|
32 731
|
|
Other Receivables |
0
|
0
|
0
|
0
|
2 392
|
1 767
|
1 953
|
2 476
|
2 752
|
1 790
|
|
Inventory |
28 131
|
32 648
|
42 429
|
45 340
|
67 962
|
74 321
|
66 783
|
78 127
|
96 110
|
95 745
|
|
Other Current Assets |
2 611
|
1 434
|
2 175
|
3 700
|
3 070
|
5 468
|
4 873
|
4 691
|
9 621
|
9 395
|
|
Total Current Assets |
62 363
|
83 572
|
79 798
|
101 624
|
115 558
|
128 278
|
142 722
|
164 708
|
175 102
|
155 391
|
|
PP&E Net |
30 412
|
29 750
|
34 107
|
38 786
|
47 417
|
54 045
|
55 710
|
59 201
|
68 943
|
39 289
|
|
PP&E Gross |
0
|
0
|
34 107
|
0
|
47 417
|
54 045
|
55 710
|
59 201
|
68 943
|
39 289
|
|
Accumulated Depreciation |
0
|
0
|
0
|
0
|
35 927
|
39 556
|
44 587
|
49 932
|
55 727
|
82 965
|
|
Intangible Assets |
2 857
|
2 276
|
3 575
|
5 845
|
50 131
|
45 735
|
46 721
|
56 607
|
56 957
|
39 609
|
|
Goodwill |
1 514
|
1 287
|
1 077
|
634
|
40 486
|
38 536
|
42 892
|
44 322
|
45 661
|
18 479
|
|
Note Receivable |
735
|
1 932
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Long-Term Investments |
4 203
|
8 568
|
13 602
|
8 700
|
12 426
|
10 342
|
18 717
|
9 991
|
13 837
|
7 533
|
|
Other Long-Term Assets |
837
|
1 745
|
1 298
|
920
|
2 882
|
1 428
|
76
|
1 990
|
3 072
|
258
|
|
Other Assets |
1 514
|
1 287
|
1 077
|
634
|
40 486
|
38 536
|
42 892
|
44 322
|
45 661
|
18 479
|
|
Total Assets |
102 921
N/A
|
129 130
+25%
|
139 834
+8%
|
161 128
+15%
|
268 900
+67%
|
278 364
+4%
|
306 838
+10%
|
336 819
+10%
|
363 572
+8%
|
260 559
-28%
|
|
Liabilities | |||||||||||
Accounts Payable |
22 298
|
22 935
|
32 755
|
30 193
|
47 598
|
50 686
|
44 172
|
61 750
|
65 359
|
48 123
|
|
Accrued Liabilities |
1 171
|
1 031
|
0
|
1 797
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Short-Term Debt |
4 070
|
11 856
|
2 750
|
14 720
|
29 116
|
28 540
|
29 174
|
37 613
|
53 287
|
60 881
|
|
Current Portion of Long-Term Debt |
3 769
|
4 478
|
4 902
|
4 723
|
8 080
|
6 959
|
8 261
|
9 134
|
9 826
|
24 648
|
|
Other Current Liabilities |
7 574
|
6 421
|
9 690
|
12 829
|
8 569
|
11 209
|
10 230
|
14 193
|
15 102
|
13 819
|
|
Total Current Liabilities |
38 883
|
46 721
|
51 618
|
64 262
|
93 363
|
97 394
|
91 837
|
122 690
|
143 574
|
147 471
|
|
Long-Term Debt |
11 705
|
12 591
|
9 332
|
10 464
|
78 674
|
85 625
|
90 739
|
87 045
|
86 021
|
77 102
|
|
Deferred Income Tax |
267
|
268
|
925
|
331
|
5 226
|
2 823
|
3 329
|
4 521
|
14 711
|
10 160
|
|
Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1 343
|
1 268
|
379
|
|
Other Liabilities |
3 256
|
3 355
|
3 472
|
3 474
|
8 466
|
4 980
|
4 610
|
5 393
|
6 831
|
12 053
|
|
Total Liabilities |
54 111
N/A
|
62 935
+16%
|
65 347
+4%
|
78 531
+20%
|
185 729
+137%
|
190 822
+3%
|
190 515
0%
|
220 992
+16%
|
252 405
+14%
|
247 165
-2%
|
|
Equity | |||||||||||
Common Stock |
13 558
|
19 976
|
19 976
|
19 976
|
19 976
|
19 976
|
23 360
|
23 360
|
23 360
|
25 975
|
|
Retained Earnings |
24 471
|
28 140
|
33 343
|
42 849
|
45 050
|
51 912
|
55 016
|
57 365
|
50 822
|
55 657
|
|
Additional Paid In Capital |
12 274
|
18 678
|
18 684
|
18 796
|
18 845
|
18 827
|
21 896
|
21 896
|
21 896
|
24 511
|
|
Unrealized Security Profit/Loss |
411
|
458
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Treasury Stock |
1 904
|
1 753
|
1 543
|
0
|
9 401
|
9 046
|
2 893
|
2 562
|
2 267
|
2 124
|
|
Other Equity |
0
|
696
|
897
|
771
|
8 701
|
5 873
|
18 944
|
15 768
|
17 356
|
20 689
|
|
Total Equity |
48 810
N/A
|
66 195
+36%
|
74 487
+13%
|
82 597
+11%
|
83 171
+1%
|
87 542
+5%
|
116 323
+33%
|
115 827
0%
|
111 167
-4%
|
13 394
-88%
|
|
Total Liabilities & Equity |
102 921
N/A
|
129 130
+25%
|
139 834
+8%
|
161 128
+15%
|
268 900
+67%
|
278 364
+4%
|
306 838
+10%
|
336 819
+10%
|
363 572
+8%
|
260 559
-28%
|
|
Shares Outstanding | |||||||||||
Common Shares Outstanding |
51
|
60
|
60
|
60
|
56
|
56
|
64
|
64
|
64
|
70
|